Results · Apr-Jun 2026
Sanofi India Q1 FY27 results
Sales grew 8% to ₹438 crore from ₹406 crore in Apr-Jun 2025.
Operating profit grew 21% to ₹115 crore, an operating margin of 26.3% (up 3.0 points from a year ago).
Net profit grew 20% to ₹83.5 crore from ₹69.5 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −7%, net profit −19%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 437.7 | 406.3 | +8% |
| Operating profit (EBITDA) | 115.3 | 94.9 | +21% |
| Operating margin | 26.3% | 23.4% | +3.0 pts |
| Net profit | 83.5 | 69.5 | +20% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Sanofi India calls this quarter Apr-Jun 2026. From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.